FIT Biotech Oy (FITBIO):企業の財務・戦略的SWOT分析

◆英語タイトル:FIT Biotech Oy (FITBIO) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C14958
◆発行会社(調査会社):GlobalData
◆発行日:2019年3月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フィンランド
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD300 ⇒換算¥44,400見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD600 ⇒換算¥88,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥133,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
FIT Biotech Oy (FIT Biotech), formerly Finnish Immunotechnology Oy is a biotechnology company that develops and commercializes gene-based treatments for cancer and a range of infectious diseases. Its patented gene transfer technology is used for the development of drug candidates which include FIT-06, a DNA vaccine for treating HIV; FIT-101 targeting cancer; and FIT-103 against infectious diseases.The company also develops recombinant proteins, diagnostic products, artificial immunogens, antibody technologies, and tuberculosis vaccine. It has drug development and collaborative projects with other biotechnology companies, pharmaceutical companies and academic research institutions. FIT Biotech is headquartered in Tampere, Finland.

FIT Biotech Oy Key Recent Developments

Feb 25,2019: FIT Biotech Oy: The Board of Directors of FIT Biotech Oy has decided to file for bankruptcy
Jan 07,2019: Changes in FIT Biotech’s board of directors
Jan 03,2019: Changes in FIT Biotech’s management
Jan 03,2019: Changes in FIT Biotech’s board of directors
Jan 03,2019: FIT Biotech has received a notice from the Finland Arbitration Institute concerning the request by Bracknor Invest to initiate arbitration proceeding under the FAI rules

This comprehensive SWOT profile of FIT Biotech Oy provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of FIT Biotech Oy including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

FIT Biotech Oy – Key Information
FIT Biotech Oy – Overview
FIT Biotech Oy – Key Employees
FIT Biotech Oy – Key Employee Biographies
FIT Biotech Oy – Key Operational Heads
FIT Biotech Oy – Major Products and Services
FIT Biotech Oy – History
FIT Biotech Oy – Company Statement
FIT Biotech Oy – Locations And Subsidiaries
FIT Biotech Oy – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

FIT Biotech Oy – Business Description
FIT Biotech Oy – Corporate Strategy
FIT Biotech Oy – SWOT Analysis
SWOT Analysis – Overview
FIT Biotech Oy – Strengths
FIT Biotech Oy – Weaknesses
FIT Biotech Oy – Opportunities
FIT Biotech Oy – Threats
FIT Biotech Oy – Key Competitors

Section 3 – Company Financial Performance Charts

FIT Biotech Oy – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

FIT Biotech Oy, Key Information
FIT Biotech Oy, Key Ratios
FIT Biotech Oy, Share Data
FIT Biotech Oy, Major Products and Services
FIT Biotech Oy, History
FIT Biotech Oy, Key Employees
FIT Biotech Oy, Key Employee Biographies
FIT Biotech Oy, Key Operational Heads
FIT Biotech Oy, Other Locations
FIT Biotech Oy, Subsidiaries
FIT Biotech Oy, Key Manufacturing facilities
FIT Biotech Oy, Key Competitors
FIT Biotech Oy, SWOT Analysis
FIT Biotech Oy, Ratios based on current share price
FIT Biotech Oy, Annual Ratios
FIT Biotech Oy, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

FIT Biotech Oy, Performance Chart
FIT Biotech Oy, Ratio Charts

★海外企業調査レポート[FIT Biotech Oy (FITBIO):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Wintershall Holding GmbH:石油・ガス:M&Aディール及び事業提携情報
    Summary Wintershall Holding GmbH (Wintershall) explores for production of oil and natural gas. It operates as a subsidiary of BASF Group. The company holds expertise in conducting geological studies, geophysical measurements, seismic surveys, reservoir modeling, field development, onshore and offsho …
  • Dover Corporation:企業の戦略・SWOT・財務分析
    Dover Corporation - Strategy, SWOT and Corporate Finance Report Summary Dover Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Mochida Pharmaceutical Co Ltd (4534):企業の財務・戦略的SWOT分析
    Mochida Pharmaceutical Co Ltd (4534) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • TTCL Public Company Limited (TTCL):電力:M&Aディール及び事業提携情報
    Summary TTCL Public Company Limited (TTCL), a subsidiary of Italian-Thai Development Public Company Limited, is a provider of engineering and construction services. The company offers integrated engineering, procurement and construction (EPC) services, feasibility study and project management servic …
  • Interstate Hotels & Resorts Inc:企業のM&A・事業提携・投資動向
    Interstate Hotels & Resorts Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Interstate Hotels & Resorts Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers …
  • MedDay SA-製薬・医療分野:企業M&A・提携分析
    Summary MedDay SA (MedDay) is a biotechnology company that develops drugs for brain metabolism to treat diseases of the nervous system. The company provides clinical and pharmaceutical development in the field of rare inborn errors of metabolism. Its pipeline products include molecules such as MD100 …
  • Chromatin Inc:企業のM&A・事業提携・投資動向
    Chromatin Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Chromatin Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …
  • Orpea SA (ORP):企業の財務・戦略的SWOT分析
    Summary Orpea SA (Orpea) is a healthcare consulting company that offers clinical care services. The company provides services such as suite care clinic services, retirement homes, and mental hospital services, among others. Its mental hospital services include treatment of mood disorders, overuse sy …
  • Fortune Electric Co Ltd (1519):企業の財務・戦略的SWOT分析
    Summary Fortune Electric Co Ltd (Fortune Electric) is a power company that manufactures and markets transformers and accessories. The company provides products such as distribution transformers, power transformers, cast resin transformers and amorphous metal alloy core transformers, among others. It …
  • Organogenesis Inc:医療機器:M&Aディール及び事業提携情報
    Summary Organogenesis Inc (Organogenesis) is a regenerative medicine company that operates in the areas of bioactive wound healing and soft tissue regeneration. The company’s products include apligraf and dermagraft. Its dermagraft is used for the treatment of full-thickness diabetic foot ulcers. Or …
  • Sumitomo Electric Industries, Ltd.:企業の戦略・SWOT・財務分析
    Sumitomo Electric Industries, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Sumitomo Electric Industries, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Dah Chong Hong Holdings Ltd (1828):企業の財務・戦略的SWOT分析
    Dah Chong Hong Holdings Ltd (1828) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Walker Greenbank PLC:企業の戦略・SWOT・財務情報
    Walker Greenbank PLC - Strategy, SWOT and Corporate Finance Report Summary Walker Greenbank PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Censa Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Censa Pharmaceuticals Inc (Censa Pharmaceuticals) is a pharmaceutical company that develops and commercializes therapeutics for the treatment of rare central nervous system (CNS) disorders. The company provides product pipeline such as therapies for the treatment of extremely rare disorders …
  • Ascena Retail Group Inc:企業の戦略的SWOT分析
    Ascena Retail Group Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • ASML Holding N.V.:企業の戦略・SWOT・財務分析
    ASML Holding N.V. - Strategy, SWOT and Corporate Finance Report Summary ASML Holding N.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • CooperSurgical Inc-医療機器分野:企業M&A・提携分析
    Summary CooperSurgical Inc (CooperSurgical), a subsidiary of The Cooper Companies Inc is a medical device company that offers surgical instrument. The company offers surgical products, clinic and office products, labor and delivery products, and critical care products. Its surgical products include …
  • Hornbeck Offshore Services Inc (HOS):企業の財務・戦略的SWOT分析
    Hornbeck Offshore Services Inc (HOS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Aeterna Zentaris Inc (AEZS):医療機器:M&Aディール及び事業提携情報
    Summary Aeterna Zentaris Inc (Aeterna Zentaris) is a specialty biopharmaceutical company that focuses on the development and commercialization of novel pharmaceutical therapies for the treatment of endocrine disorders. The company’s lead product, macimorelin, a ghrelin receptor agonist and orally-ac …
  • Endava Limited
    Endava Limited - Strategy, SWOT and Corporate Finance Report Summary Endava Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆